Mesothelin-Targeting Logic-gated CAR T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mesothelin-Targeting Logic-gated CAR T, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression [Phase 1, Phase 2]